Adherence to lipid-lowering therapy and risk for cardiovascular disease and death in type 1 diabetes mellitus: a population-based study from the Swedish National Diabetes Register

AIMS/HYPOTHESIS: Dyslipidemia is an important modifiable risk factor and lipid-lowering treatment (LLT) is essential to reduce the risk of cardiovascular disease (CVD). Studies in type 2 diabetes indicate that low adherence to statin therapy is a barrier to reach full protective potential, and less...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMJ Open Diabetes Res Care
Main Authors: Hero, Christel, Karlsson, Sofia Axia, Franzén, Stefan, Svensson, Ann-Marie, Miftaraj, Mervete, Gudbjörnsdottir, Soffia, Andersson Sundell, Karolina, Eliasson, Björn, Eeg-Olofsson, Katarina
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2020
Assuntos:
Epidemiology/Health Services Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7039602/
https://ncbi.nlm.nih.gov/pubmed/31958300
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjdrc-2019-000719
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados